CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission

Blood

Volumn 89, Issue 8, 1997, Pages 3039-3047

  Soiffer, Robert J ^a   Fairclough, Diane ^a   Robertson, Michael ^a   Alyea, Edwin ^a   Anderson, Kenneth ^a   Freedman, Arnold ^a   Bartlett Pandite, Lini ^a   Fisher, David ^a   Schlossman, Robert L ^a   Stone, Richard ^a   Murray, Christine ^a   Freeman, Andrea ^a   Marcus, Karen ^a   Mauch, Peter ^a   Nadler, Lee ^a   Ritz, Jerome ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; T LYMPHOCYTE ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; LYMPHOCYTE DEPLETION; MALE; MORTALITY; ORGAN DONOR; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE SUBPOPULATION; WHOLE BODY RADIATION;

EID: 0030896218     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.8.3039     Document Type: Article

References (60)

1. Forman SJ, Blume KG: Allogeneic bone marrow transplantation for acute leukemia. Hematol Oncol Clin North Am 4:517, 1990
2. Bortin MM, Horowitz MM, Rimm AA: Increasing utilization of allogeneic bone marrow transplantation. Ann Intern Med 116:505, 1992
3. Zhang MJ, Hoelzer D, Horowitz MM, Gale RP, Messerer D, Klein JP, Loffler H, Sobocinski KA, Thiel E, Weisdorf DJ: Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. Ann Intern Med 123:428, 1995
4. Zittoun R, Mandelli F, Willemze R: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 331:217, 1995
5. Sebban C, Lepage E, Vernant JP, Gluckman E, Attal M, Reiffers J, Sutton L, Racodot E, Michallet M, Maraninchi D, Dreyfus F, Fiere D: Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: A comparative study. J Clin Oncol 12:2580, 1994
6. Archimbaud E, Thomas X, Michallet M, Jaubert J, Troncy J, Guyotat D, Fiere D: Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia. J Clin Oncol 12:262, 1994
7. Mayer RJ: Acute leukemias in adults: An overview of recent strategics. J Cancer Res Clin Oncol 116:94, 1990
8. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, Beatty PG, Doney K, McDonald GB, Sanders JE, Sullivan KM, Storb R, Thomas ED, Witherspoon RP, Lomen P, Hannigan J, Hansen JA: A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood 76:1464, 1990
9. Wingard JR, Piantadosi S, Vogelsang GB, Farmer ER, Jabs DA, Levin LS, Beschorner WE, Cahill RA, Miller DF, Harrison D, Saral R, Santos GW: Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 74:1428, 1989
10. Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L, Buckner CD, Anasetti C, Appelbaum FR, Badger C, Beatty P, Bensinger W, Berenson, R, Bigelow C, Cheever MA, Clift R, Deeg HJ, Doney K, Greenberg P, Hansen JA, Hill R, Loughran T, Martin P, Neiman P, Petersen FB, Sanders J, Singer J, Stewart P, Thomas ED: Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73:1720, 1989
11. Korngold R, Sprent J: T cell subsets and graft-versus-host disease. Transplantation 44:335, 1987
12. Wagner JE, Donnenberg AD, Noga SJ, Cremo CA, Gao IK, Yin HJ, Vogelsang GB, Rowley S, Saral R, Santos GW: Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: Results of a phase I clinical trial. Blood 72:1168, 1988
13. Young JW, Papadopoulos EB, Cunningham I, Castro-Malaspina H, Flomenberg N, Carabasi MH, Gulati SC, Brochstein JA, Heller G, Black P, Collins NH, Shank B, Kernan NA, O'Reilly RJ: T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission. Blood 79:3380, 1992
14. Filipovich AH, Vallera D, McGlave P, Polich D, Gajl-Peczalska K, Haake R, Lasky L, Blazar B, Ramsay NK, Kersey J, Weisdorf D: T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease. Transplantation 50:410, 1990
15. Hale G, Cobbold S, Waldmann H: T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation. Transplantation 45:753, 1988
16. Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA, Herzig RH, Hong R, Masaoka T, Rimm AA, Ringden O, Speck B, Weiner RS, Bortin MM: T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120, 1991
17. Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffmann RG, Jacobsen SJ, Marmont AM, McGlave PB, Messner HA, Rimm AA, Rozman C, Speck B, Tura S, Weiner RS, Bortin MM: Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk for relapse associated with T-cell depletion. Ann Intern Med 108:806, 1988
18. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ: Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation 43:842, 1987
19. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Dumam DM: Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520, 1988
20. Mitsuyasu RT, Champlin RE, Gale RP, Ho WG, Lenarsky C, Winston D, Selch M, Elashoff R, Giorgi JV, Wells J, Terasaki P, Billing R, Feig S: Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial. Ann Intern Med 105:20, 1986
21. Frame JN, Collins NH, Cartagena T, Waldmann H, O'Reilly RJ, Dupont B, Kernan NA: T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads. Transplantation 47:984, 1989
22. Frame JN, Sheehy P, Cartagena T, Cirrincione C, O'Reilly RJ, Dupont B, Kernan NA: Optimal conditions for in vitro T cell depletion of human bone marrow by Campath-1a plus complement as demonstrated by limiting dilution analysis. Bone Marrow Transplant 4:55, 1989
23. Reinherz EL, Geha R, Rappaport JM, Wilson M, Penta AC, Hussey RE, Fitzgerald KA, Daley JF, Levine H, Rosen FS, Schlossman SF: Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci USA 79:6047, 1982
24. Rohatiner A, Gelber R, Schlossman SF, Ritz J: Depletion of T cells from human bone marrow using monoclonal antibodies and rabbit complement. A quantitative and functional analysis. Transplantation 42:73, 1986
25. Soiffer RJ, Murray C, Mauch P, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Robertson MJ, Spector N, Gonin R, Miller KB, Rudders RA, Freeman A, Blake K, Nadler LM, Ritz J: Prevention of graft-versus-host disease by selective depletion of CD6 positive T lymphocytes from donor bone marrow. J Clin Oncol 10:1191, 1992
26. Soiffer RJ, Mauch P, Tarbell NJ, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Murrey CI, Coral F, Bosserman L, Dear K, Nadler LM, Ritz J: Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow. Bone Marrow Transplant 7:23, 1991
27. Soiffer RJ, Murray C, Cochran K, Cameron C, Wang E, Schow PW, Daley JF, Ritz J: Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation. Blood 79:517, 1992
28. Mehta C, Patel N: A network algorithm for the exact treatment of Fisher's exact test in RxC contingency tables. J Am Stat Assoc 78:427, 1983
29. Glucksberg H, Storb R, Fefer A, Buckner CD, Nesman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipients of HLA matched sibling donors. Transplantation 18:295, 1974
30. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
31. Armitage P, Berry G: Statistical Methods in Medical Research. Oxford, UK, Oxford, 1987
32. Soiffer RJ, Dear K, Rabinowe SN, Anderson KC, Freedman AS, Murray C, Tarbell NJ, Mauch P, Nadler LM, Ritz J: Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation. Transplantation 52:1014, 1991
33. Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K, Martin PJ, Sullivan KM, Sanders J, Witherspoon RP: Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate [see comments]. Blood 80:1838, 1992
34. Mitus AJ, Miller KB, Schenkein DP, Ryan HF, Parsons SK, Wheeler C, Antin JH: Improved survival for patients with acute myelogenous leukemia. J Clin Oncol 13:560, 1995
35. Ringden O, Horowitz MM, Sondel P, Gale RP, Biggs JC, Champlin RE, Deeg HJ, Dicke K, Masaoka T, Powles RL, Rimm AA, Rozman C, Sobocinski KA, Speck B, Zwann F, Bortin MM: Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 81:1094, 1993
36. Engelhard D, Or R, Strauss N, Morag A, Aker M, Naparstek E, Breuer R, Ravid Z, Sarov I, Lijovetzky G, Slavin S: Cytomegalovirus infection and disease after T cell depleted allogeneic bone marrow transplantation for malignant hematologic diseases. Transplant Proc 21:3101, 1989
37. Bunjes D, Hertenstein B, Wiesneth M, Stefanic M, Novotny J, Duncker C, Heit W, Arnold R, Heimpel H: In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: Comparison with cyclosporin/methotrexate. Bone Marrow Transplant 15:563, 1995
38. Winston DJ, Ho WG, Lin CH, Bartoni K, Budinger MD, Gale RP, Champlin RE: Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 106:12, 1987
39. Meyers JD, Flournoy N, Thomas ED: Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153:478, 1986
40. Kameoka J, Sato T, Torimoto Y, Sugita K, Soiffer RJ, Schlossman SF, Ritz J, Morimoto C: Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation. Blood 85:1132, 1995
41. Sugita K, Nojima Y, Tachibana K, Soiffer RJ, Murray C, Schlossman SF, Ritz J, Morimoto C: Prolonged impairment of VLA-mediated T cell proliferation via the CD3 pathway following T cell depleted allogeneic bone marrow transplantation. J Clin Invest 94:481, 1994
42. Soiffer R, Bosserman L, Murray C, Cochran K, Daley J, Ritz J: Reconstitution of T cell function following CD6-depleted allogeneic bone marrow transplantation. Blood 76:235, 1990
43. Weiden PL, Flournoy MS, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R: Anti-leukemic effect of graft-versus-host-disease in human recipients of allogeneic-marrow grafts. N Engl J Med 300:1068, 1979
44. Antin JH: Graft-versus-leukemia: No longer an epiphenomenon. Blood 82:2273, 1993
45. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
46. Sykes M: Dissociating graft-vs-host disease from the graft-vs-leukemia effect of allogeneic T cells: The potential role of IL-2. Bone Marrow Transplant 10:1, 1992
47. Johnson B, Drobyski W, Truitt R: Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant 11:329, 1993
48. Weiss L, Lubin I, Factorowich I, Lapidot Z, Reich S, Reisner Y, Slavin S: Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2. J Immunol 153:2562, 1994
49. Nimer, SD, Giorgi J, Gajewski JL, Ku N, Schiller GJ, Lee K, Territo M, Ho W, Feig S, Selch M, Isacescu V, Reichert TA, Champlin RE: Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial. Transplantation 57:82, 1994
50. Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringden O, Stone JAV, Bortin MM: Identical-twin bone marrow transplants for leukemia. Ann Intern Med 120:646, 1994
51. Sullivan KM, Storb R, Buckner CD, Fefer A, Fisher L, Weiden PL, Witherspoon RP, Appelbaum FR, Banaji M, Hansen J, Martin P, Sanders JE, Singer J, Thomas ED: Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. N Engl J Med 320:828, 1989
52. McGlave PB, Haake RJ, Bostrom BC, Brunning R, Hurd DD, Kim TH, Nesbit ME, Vercellotti GM, Weisdorf D, Woods WG, Ramsay NKC, Kersey JH: Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission. Blood 72:1512, 1988
53. Doney K, Fisher LD, Appelbaum FR, Buckner CD, Storb R, Singer J, Fefer A, Anasetti C, Beatty P, Bensinger W, Cliff R, Hansen J, Hill R, Loughran TP Jr, Martin P, Petersen FB, Sanders J, Sullivan KM, Stewart P, Weiden P, Witherspoon R, Thomas ED: Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation: Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone Marrow Transplant 7:453, 1991
54. Chao NJ, Forman SJ, Schmidt GM, Snyder DS, Amylon MD, Konrad PN, Nademanee AP, O'Donnell MR, Parker PM, Stein AS, Smith E, Wong RM, Hoppe RT, Blume KG: Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood 78:1923, 1991
55. Gale RP, Horowitz MM, Weiner RS, Ash RC, Atkinson L, Babu R, Dicke KA, Klein JP, Lowenberg B, Reiffers J, Rimm AA, Rowlings PA, Sandberg AA, Sobocinski KA, Veum-Stone J, Bortin MM: Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant 16:203, 1995
56. Benyunes MC, Massumoto C, York A, Higuchi CM, Buckner CD, Thompson JA, Petersen FB, Fefer A: Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant 12:159, 1993
57. Attal M, Blaise D, Marit G, Payen C, Michallet M, Vernant J, Sauvage C, Troussard X, Nedellec G, Pico J, Huguet F, Stoppa A, Braustet A, Sotto J, Pris J, Maraninchi D, Reiffers J: Consolidation treatment of adult acute lymphoblastic leukemia: A prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. Blood 86:1619, 1995
58. Naparstek E, Or R, Nagler A, Cividalli G, Engelhard D, Aker M, Gimon Z, Manny N, Sacks T, Tochner Z, Weiss L, Samuel S, Brautbar C, Hale G, Waldmann H, Steinberg SM, Slavin S: T-cell depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse. Br J Haematol 89:506, 1995
59. Clift RA, Buckner CD, Appelbaum FR, Bryant E, Bearman SI, Peterson FB, Fisher LD, Anasetti C, Beatty P, Bensinger WI, Doney K, Hill RS, McDonald GB, Martin P, Meyers J, Sanders J, Singer J, Stewart P, Sullivan KM, Witherspoon R, Storb R, Hansen JA, Thomas ED: Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens. Blood 77:1660, 1991
60. Geller RB, Myers S, Devine S, Larson RA, Williams SF, Park CL, O'Toole K, Chandler C, Topper RL: Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation. Bone Marrow Transplant 9:41, 1992